In considering Sulf1 or Sulf2 as drug targets, the main consideration is the increasing evidence implicating the Sulfs in cancer and whether these are responsible for augmenting cancer cell growth or inhibiting it (31, 32, 37, 101, 165). Here, SULF2 is linked to cancer.